• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

UnitedHealth Launching Post-Discharge Home Program for Group Medicare Advantage Plans

Share:

May 19, 2021

UnitedHealthcare will soon be launching UnitedHealthcare Healthy at Home, the insurer said last week, an offering that’s designed to help retirees safely make the transition back home after being discharged from a hospital or skilled nursing facility.

Specifically created for Group Retiree Medicare Advantage plans, the plan is geared around providing access to benefits that address a range of social needs, with an eye toward keeping retirees healthy in their homes. Access will be facilitated through employers and plan sponsors.

WHAT’S THE IMPACT?

Included in the new program is post-discharge meal delivery, which will provide up to 28 meals (two meals per day for two weeks) following all inpatient or skilled nursing facility discharges for retirees when referred by a UnitedHealthcare advocate. These advocates, UnitedHealth said, will contact patients following their discharges.

Post-discharge transportation will also be provided and will include up to 12 one-way rides to and from medically-related appointments and to the pharmacy following every inpatient or skilled nursing facility discharge.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The final component is in-home personal care, which will provide up to six hours of in-home care following all discharges. Retirees will receive assistance with daily living activities to support their recovery and follow-up care to help reduce the risk of hospital readmission.

Services will be available every time a retiree is discharged from a hospital or skilled nursing facility. UnitedHealthcare Healthy at Home is being made available to employers with Group Retiree Medicare Advantage plans beginning Jan. 1, 2022.

THE LARGER TREND

In a working paper published in September 2020 from the Mercatus Center, a free-market-oriented think tank based out of George Mason University, Professor Philip E. Auerswald argued that removing labor market barriers and technical barriers to entry is vital for realizing the benefits of in-home healthcare.

Home healthcare, as Auerswald describes it, comprises medical house calls, health agency care, technologies such as remote patient-monitoring devices and telehealth.

In March, the U.S. Department of Justice said it was pursuing an investigation of UnitedHealth Group’s $13 billion acquisition of data analytics company Change Healthcare, spurred in part by a letter sent to regulators this month by the American Hospital Association raising antitrust concerns.

According to Change Healthcare in a filing with the Securities and Exchange Commission, both it and UnitedHealth Group received a request for additional information from the DOJ in connection with the ongoing review of the merger, which pushed back the initial 30-day window of the investigation.

UnitedHealth Group encompasses UnitedHealthcare, considered the largest insurer in the nation.

Source: HealthcareFinancenews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • PwC Projects ’Flurry of Deals’ Across Life Science IndustryPwC Projects ’Flurry of Deals’ Across Life Science Industry
  • Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcChiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
  • Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine PlatformRapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform
  • Mission Bio Announces and Launches Single-Cell Measurable Residual Disease (MRD) AssayMission Bio Announces and Launches Single-Cell Measurable Residual Disease (MRD) Assay
  • Medtainer, Inc. Completes Acquisition of Advanced Container Technologies, Inc.Medtainer, Inc. Completes Acquisition of Advanced Container Technologies, Inc.
  • Covid-19 Impact on Bio-pharma Market Report Analysis By Various Services, Offering, Platforms, Significant Growth, Competitive Insights, Business Strategy Opportunities & Demand Analysis Till 2026Covid-19 Impact on Bio-pharma Market Report Analysis By Various Services, Offering, Platforms, Significant Growth, Competitive Insights, Business Strategy Opportunities & Demand Analysis Till 2026
  • Webtools Health in New Zealand Launches Connected Care PlatformWebtools Health in New Zealand Launches Connected Care Platform
  • Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United StatesCovalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications